// App-Quantinova.ai

P179 : Glucocorticoid exposure and link to serious adverse events in patients with ANCA-associated vasculitis

Researchers

Presenter

  • Philip Spearpoint

Principal Investigators

  • Cormac Sammon

  • Antonio Ramirez de

  • Arellano Serna

  • Peter Rutherford

Medical Centers

  • Health Outcomes, Vifor Pharma, Zurich, SWITZERLAND

  • Health Outcomes, PHMR, London, UNITED KINGDOM

  • Vifor Pharma, Medical Affairs, Zurich, SWITZERLAND

Locations

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved